Summary
This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.
Industry Chain
Raw Materials
Cost
Technology
Consumer Preference
Industry Overall:
History
Development & Trend
Market Competition
Trade Overview
Policy
Region (North America, Europe, Asia-Pacific, South America, Middle East, Africa):
Regional Market
Production Development
Sales
Regional Trade
Regional Forecast
Company (GE Healthcare (US), Bracco Imaging (Italy), Bayer HealthCare (Germany), Guerbet (France), Daiichi Sankyo (Japan), Daiichi Sankyo (Japan), Unijules Life Sciences (India), J.B. Chemicals and Pharmaceuticals (India), Spago Nanomedicine (Sweden), Taejoon Pharm (South Korea), Jodas (India), Magnus Health (India) etc.):
Company Profile
Product & Service
Business Operation Data
Market Share
Investment Analysis:
Market Features
Investment Opportunity
Investment Calculation
Table of Content
Part 1 Industry Overview
1.1 Radiocontrast Agent Industry
1.1.1 Definition
1.1.2 Industry Trend
1.2 Industry Chain
1.2.1 Upstream
1.2.2 Technology
1.2.3 Cost Structure
1.2.4 Consumer Preference
1.2.2 Downstream
Part 2 Industry Overall
2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview
Part 3 Radiocontrast Agent Market by Product
3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast
4 Key Companies List
4.1 GE Healthcare (US) (Company Overview, Sales Data etc.)
4.1.1 Company Overview
4.1.2 Products and Services
4.1.3 Business Analysis
4.2 Bracco Imaging (Italy) (Company Overview, Sales Data etc.)
4.2.1 Company Overview
4.2.2 Products and Services
4.2.3 Business Analysis
4.3 Bayer HealthCare (Germany) (Company Overview, Sales Data etc.)
4.3.1 Company Overview
4.3.2 Products and Services
4.3.3 Business Analysis
4.4 Guerbet (France) (Company Overview, Sales Data etc.)
4.4.1 Company Overview
4.4.2 Products and Services
4.4.3 Business Analysis
4.5 Daiichi Sankyo (Japan) (Company Overview, Sales Data etc.)
4.5.1 Company Overview
4.5.2 Products and Services
4.5.3 Business Analysis
4.6 Daiichi Sankyo (Japan) (Company Overview, Sales Data etc.)
4.6.1 Company Overview
4.6.2 Products and Services
4.6.3 Business Analysis
4.7 Unijules Life Sciences (India) (Company Overview, Sales Data etc.)
4.7.1 Company Overview
4.7.2 Products and Services
4.7.3 Business Analysis
4.8 J.B. Chemicals and Pharmaceuticals (India) (Company Overview, Sales Data etc.)
4.8.1 Company Overview
4.8.2 Products and Services
4.8.3 Business Analysis
4.9 Spago Nanomedicine (Sweden) (Company Overview, Sales Data etc.)
4.9.1 Company Overview
4.9.2 Products and Services
4.9.3 Business Analysis
4.10 Taejoon Pharm (South Korea) (Company Overview, Sales Data etc.)
4.10.1 Company Overview
4.10.2 Products and Services
4.10.3 Business Analysis
4.11 Jodas (India) (Company Overview, Sales Data etc.)
4.12 Magnus Health (India) (Company Overview, Sales Data etc.)
Part 5 Market Competition
5.1 Companies Competition
5.2 Industry Competition Structure Analysis
5.2.1 Rivalry
5.2.2 Threat of New Entrants
5.2.3 Substitutes
5.2.4 Bargaining Power of Suppliers
5.2.5 Bargaining Power of Buyers
Part 6 Market Demand by Segment
6.1 Demand Situation
6.1.1 Industry Application Status
6.1.2 Industry SWOT Analysis
6.1.2.1 Strengths
6.1.2.2 Weaknesses
6.1.2.3 Opportunities
6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast
Part 7 Region Operation
7.1 Regional Market
7.2 Production and Sales by Region
7.2.1 Production
7.2.2 Sales
7.2.3 Trade
7.3 Regional Forecast
Part 8 Market Investment
8.1 Market Features
8.1.1 Product Features
8.1.2 Price Features
8.1.3 Channel Features
8.1.4 Purchasing Features
8.2 Investment Opportunity
8.2.1 Regional Investment Opportunity
8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
8.3.1 Cost Calculation
8.3.2 Revenue Calculation
8.3.3 Economic Performance Evaluation
Part 9 Conclusion
Table Global Radiocontrast Agent Market 2012-2017, by Type, in USD Million
Table Global Radiocontrast Agent Market 2012-2017, by Type, in Volume
Table Global Radiocontrast Agent Market Forecast 2018-2023, by Type, in USD Million
Table Global Radiocontrast Agent Market Forecast 2018-2023, by Type, in Volume
Table GE Healthcare (US) Overview List
Table Radiocontrast Agent Business Operation of GE Healthcare (US) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bracco Imaging (Italy) Overview List
Table Radiocontrast Agent Business Operation of Bracco Imaging (Italy) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bayer HealthCare (Germany) Overview List
Table Radiocontrast Agent Business Operation of Bayer HealthCare (Germany) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Guerbet (France) Overview List
Table Radiocontrast Agent Business Operation of Guerbet (France) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Daiichi Sankyo (Japan) Overview List
Table Radiocontrast Agent Business Operation of Daiichi Sankyo (Japan) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Daiichi Sankyo (Japan) Overview List
Table Radiocontrast Agent Business Operation of Daiichi Sankyo (Japan) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Unijules Life Sciences (India) Overview List
Table Radiocontrast Agent Business Operation of Unijules Life Sciences (India) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table J.B. Chemicals and Pharmaceuticals (India) Overview List
Table Radiocontrast Agent Business Operation of J.B. Chemicals and Pharmaceuticals (India) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Spago Nanomedicine (Sweden) Overview List
Table Radiocontrast Agent Business Operation of Spago Nanomedicine (Sweden) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Taejoon Pharm (South Korea) Overview List
Table Radiocontrast Agent Business Operation of Taejoon Pharm (South Korea) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Jodas (India) Overview List
Table Radiocontrast Agent Business Operation of Jodas (India) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Magnus Health (India) Overview List
Table Radiocontrast Agent Business Operation of Magnus Health (India) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Radiocontrast Agent Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Radiocontrast Agent Sales Revenue Share, by Companies, in USD Million
Table Global Radiocontrast Agent Sales Volume 2012-2017, by Companies, in Volume
Table Global Radiocontrast Agent Sales Revenue Share, by Companies in 2017, in Volume
Table Radiocontrast Agent Demand 2012-2017, by Application, in USD Million
Table Radiocontrast Agent Demand 2012-2017, by Application, in Volume
Table Radiocontrast Agent Demand Forecast 2018-2023, by Application, in USD Million
Table Radiocontrast Agent Demand Forecast 2018-2023, by Application, in Volume
Table Global Radiocontrast Agent Market 2012-2017, by Region, in USD Million
Table Global Radiocontrast Agent Market 2012-2017, by Region, in Volume
Table Radiocontrast Agent Market Forecast 2018-2023, by Region, in USD Million
Table Radiocontrast Agent Market Forecast 2018-2023, by Region, in Volume
Figure Radiocontrast Agent Industry Chain Structure
Figure Global Radiocontrast Agent Market Growth 2012-2017, by Type, in USD Million
Figure Global Radiocontrast Agent Market Growth 2012-2017, by Type, in Volume
Figure Global Radiocontrast Agent Sales Revenue Share, by Companies in 2017, in USD Million
Figure Global Radiocontrast Agent Sales Volume Share 2012-2017, by Companies, in Volume
Figure Production Development by Region
Figure Sales List by Region